Experimental mRNA vaccine cuts risk melanoma returns by 42%

When the news arrived in August that what could be the first personalized mRNA cancer vaccine had succeeded in a late-stage ...
CNN

Moderna, Merck breakthrough could usher in wave of cancer vaccines

Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at bay opens a new avenue of treatment that doctors hope will work against many types of tumors. Unlike ...
KRDO

Moderna and Merck say melanoma vaccine succeeded in large trial

(CNN) — A personalized mRNA cancer vaccine combined with the immunotherapy Keytruda succeeded in a late-stage trial for the deadly skin cancer melanoma, its makers said Wednesday, potentially opening ...
Hosted on MSN

A vaccine for melanoma recurrence? Merck, Moderna say trial promising

Merck and Moderna announced a phase 3 trial using an mRNA-based experimental vaccine delayed recurrence of melanoma in a study involving 1,137 high-risk patients. The interim study results were ...